Versant Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Cambridge, US
Board seatClare Ozawa· per SEC Form D · $30.3M raise · filed Sep 2022
Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechWaltham, US
Judith Lieberman(Co-Founder, MD, PhD)Daniel Koerwer(Executive Officer)Josh Resnick(Director)Steven James(Director)Michael Crackower(Executive Officer)Zachary McNealy(Executive Officer)
Board seatMarkus WarmuthJerel Davis· per SEC Form D · $140M raise · filed Feb 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.